Results 271 to 280 of about 328,521 (340)
This consensus highlights critical research gaps in obesity epidemiology, phenotypic heterogeneity and clinical management, calling for advanced methodologies, collaborative strategies and innovative policies to mitigate the global obesity epidemic and its socio‐economic impacts.
Federico Carbone+28 more
wiley +1 more source
Correction: Sex differences in problematic pornography use among adolescents: a network analysis. [PDF]
Villena-Moya A+10 more
europepmc +1 more source
Unraveling Audiovisual Perception Across Space and Time: A Neuroinspired Computational Architecture
Fitted on auditory localization and reaction time task data, our neurocomputational model aims to elucidate the mechanisms underlying multisensory perception in the entire spatiotemporal domain, predicting how spatial and temporal factors interact to modulate sensory perception.
Cristiano Cuppini+3 more
wiley +1 more source
Co-design of family interventions in cancer: a scoping review protocol to assess key methods and processes. [PDF]
Alfaro-Díaz C+2 more
europepmc +1 more source
Hogares y caseríos en la Navarra cantábrica en el siglo XIX. Un enfoque microanalítico
Pilar Erdozáin Azpilicueta+2 more
openalex +2 more sources
Summary Background and Objectives To examine whether changes in the Mediterranean Diet (MD) or any of its MD food groups modulate the genetic susceptibility to obesity in European youth, both in cross‐sectional and longitudinal analyses. Methods For cross‐sectional analysis, 1982 participants at baseline, 1649 in follow‐up 1 (FU1) and 1907 in follow‐up
Miguel Seral‐Cortes+20 more
wiley +1 more source
Endovascular treatment of a pseudoaneurysm in the right inferomedial genicular artery after arthroscopic anterior cruciate ligament reconstruction: a case report. [PDF]
Barrio Piqueras M+3 more
europepmc +1 more source
Abstract Background Talquetamab is the first approved G protein–coupled receptor family C group 5 member D–targeting bispecific antibody for the treatment of triple‐class exposed relapsed/refractory multiple myeloma (RRMM) on the basis of results from the phase 1/2 MonumenTAL‐1 study (ClinicalTrials.gov identifiers NCT03399799 and NCT04634552).
Carolina Schinke+21 more
wiley +1 more source